Tardak Injection 10 ml (10ml)

Tardak is for use in male dogs and cats in the following indications:
1.The treatment of hypersexuality (including vagrancy).
2.The relief of prostatic hypertrophy whether benign, carcinomatous or when due to chronic inflammatory processes. (In cases of the latter, relief cannot be expected unless appropriate accompanying therapy, such as corticoids or antibiotics is also instituted.)
3.For the treatment of circum-anal tumours.
4.For the treatment of certain forms of aggressiveness, nervousness, epileptiform seizures and corticoid-resistant pruritus (developing into dermatoses and accompanied by alopecia).
Visit www.myvetmeds.co.uk / dog / hormones-dog / tardak-injection-10-ml.htm
Product Description
About Tardak Injection 10 ml (10ml)
Tardak is for use in male dogs and cats in the following indications:
1.The treatment of hypersexuality (including vagrancy).
2.The relief of prostatic hypertrophy whether benign, carcinomatous or when due to chronic inflammatory processes. (In cases of the latter, relief cannot be expected unless appropriate accompanying therapy, such as corticoids or antibiotics is also instituted.)
3.For the treatment of circum-anal tumours.
4.For the treatment of certain forms of aggressiveness, nervousness, epileptiform seizures and corticoid-resistant pruritus (developing into dermatoses and accompanied by alopecia).
Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.
Directions For Use
Directions for Use
Route: Intramuscular or subcutaneous injection. Dose levels should be individually selected, taking into consideration the weight of the animal and the severity of the condition to be treated. The following dosage recommendations may be taken as a guideline.
Up to 10 kg
1.5?2.0 mg/kg body weight
10 to 20 kg
1.0?1.5 mg/kg body weight
20 kg and above
1.0 mg/kg body weight
In most cases it is necessary to allow two to four days to elapse before the effect of the treatment is observed.
Animals not showing improvement within eight days should be treated a second time with at least the dose level previously given.
Animals showing a favourable response can be expected to require follow-up treatment after a three to four week period. Further treatment in 'social indications' is recommended at the first sign of reappearance of the effectively controlled indication.
Active Ingredient
Tardak Injection 10 ml (10ml) ingredients
A sterile aqueous suspension for injection of micronised delmadinone acetate. Delmadinone acetate is 8-chloro-17 ?-hydroxypregna-1,4,6-triene-3,20-dione acetate. Each ml contains 10 mg delmadinone acetate. This product contains benzalkonium chloride 0.01% as a preservative.
Side Effects
Side effects of Tardak Injection 10 ml (10ml)
Owners should be clearly warned that an immediate effect cannot be expected following administration of Tardak.
Tardak should not be used in dogs already receiving progestogens.
Animals treated with Tardak at stud could show a transient reduction in fertility and libido.
Transient side-effects of increased appetite, polydipsia and polyuria have occasionally been seen following administration of Tardak. Controlling food intake will prevent an increase in bodyweight. However, where these effects are excessive, therapy should cease.
As some progestogen injections can cause local changes in the hair coat such as lightening of colour and/or hair loss, it is recommended that subcutaneous injections are given at an inconspicuous site, e.g. inner surface of the thigh.
Tardak should be used with great care when animals are under treatment with other steroids.
Tardak should not be used in diabetic animals.
Additional Data
Tardak Injection 10 ml (10ml) specification
| Specification: | Detail: |
|---|---|
| Pack Size: | 10ml |
| Brands: | Pfizer |
| Product Form: | injection |
| External Link: | http://www.noahcompendium.co.uk/Pfizer_Limited/Tardak_10_mg_ml_Suspension_for_Injection/-31160.html |
| Strength/Size: | 10 ml |

















